Higher GLP-1 RA doses and, especially, the duration of treatment influenced the risk [61]
Adherence to medication regimens is significantly improved when administration times align with established daily habits
At the end of the experiment, body weight, blood glucose, and serum hormone levels were measured
Where testing, COA or supporting documentation is available, it should be checked alongside internal research procurement requirements
It focuses, as youd expect, on obesity-related weight loss and type 2 diabetes although other metabolic conditions get a look-in, too
We follow guidelines from the FDA and Endocrine Society, which recommend that GLP-1 agonists be used alongside healthy eating, increased physical activity, and behavioral changes for the best results